Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC

por Chêne, Arnaud, Gangnard, Stéphane, Guadall, Anna, Ginisty, Hervé, Leroy, Odile, Havelange, Nicolas, Viebig, Nicola K., Gamain, Benoît
Publicado 2019

Assessment of packed bed bioreactor systems in the production of viral vaccines

por Rajendran, Ramya, Lingala, Rajendra, Vuppu, Siva Kumar, Bandi, Bala Obulapathi, Manickam, Elaiyaraja, Macherla, Sankar Rao, Dubois, Stéphanie, Havelange, Nicolas, Maithal, Kapil
Publicado 2014

Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development

por Chêne, Arnaud, Gangnard, Stéphane, Dechavanne, Célia, Dechavanne, Sebastien, Srivastava, Anand, Tétard, Marilou, Hundt, Sophia, Leroy, Odile, Havelange, Nicolas, Viebig, Nicola K., Gamain, Benoît
Publicado 2018

Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation

por Faber, Bart W., Hellwig, Stephan, Houard, Sophie, Havelange, Nicolas, Drossard, Jürgen, Mertens, Hubert, Croon, Alexander, Kastilan, Robin, Byrne, Richard, van der Werff, Nicole, van der Eijk, Marjolein, Thomas, Alan W., Kocken, Clemens H. M., Remarque, Edmond J.
Publicado 2016